Overview
- 5 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2023-03-31.
At a glance
Inspections
5
Form 483s
2
EIRs
1
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 27 Mar 2023 – 31 Mar 2023 | Human Drugs | Clean | |
| 11 Dec 2017 – 15 Dec 2017 | Human Drugs | 483 | On file |
| 30 May 2016 – 1 Jun 2016 | Human Drugs | Clean | |
| 24 Mar 2014 – 27 Mar 2014 | Human Drugs | 483 | View 483 → |
| 21 Jun 2007 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
27 Mar 2014
21 CFR 211.103
Actual vs. theoretical yields not determined
Cited by Meisha R Sampson, Meisha R Waters
Investigators
FDA investigators tied to this site in the record.
Jolanna A Norton1 insp.
Babatunde D Babalola1 insp.
Darren S Brown1 insp.
James Norman1 insp.
Nicholas L Paulin1 insp.
Meisha R Sampson1 insp.
Meisha R Waters1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.103 | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Sever Pharma Solutions AB's 2 Form 483s
Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat